|

PCSK 9 Inhibitor plus high-intensity statin Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Nanjing First Hospital, Nanjing Medical University1

Indications

  • Cardiovascular Events1
  • Percutaneous Coronary Intervention1
  • Hyperlipidemias1
  • Heart Disease1
  • Acute Coronary Syndrome1

Other1 trial

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.